Cancer Res Treat.  2013 Jun;45(2):86-94.

Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012

• Suh M
• Choi KS
• Lee YY
• Jun JK

Abstract

PURPOSE
The Korean National Cancer Screening Survey (KNCSS), a nationwide, annual cross-sectional survey, has been conducted since 2004. The current study was conducted in order to report on trends in cancer screening rates for five types of cancer (stomach, liver, colorectal, breast, and cervix uteri).
MATERIALS AND METHODS
KNCSS data were collected between 2004 and 2012. The eligible study population included cancer-free men who were 40 years of age and older and women who were 30 years of age and older. The lifetime screening rate, screening rate with recommendation, and changes in annual rates were calculated.
RESULTS
Lifetime screening rates and screening rates with recommendation for the five types of cancer rose steadily until 2010, showed a slight drop or were stable in 2011, and increased again in 2012. On average, screening rates with recommendation have shown annual increases of 4.3% (95% confidence interval [CI], 3.6 to 5.0%) for stomach cancer, 0.8% (95% CI, -0.5 to 2.1%) for liver cancer, 2.4% (95% CI, 1.3 to 3.5%) for colorectal cancer, 4.5% (95% CI, 3.9 to 5.1%) for breast cancer, and 1.3% (95% CI, 0.6 to 2.0%) for cervical cancer. Disparities in age groups and household incomes have been decreasing since 2004.
CONCLUSION
Cancer screening rates in Korea showed a significant increase from 2004 to 2012, and screening rates for gastric and breast cancer are now approaching 70%. The 10-Year Plan for Cancer Control target for screening rates was met or nearly met for all cancer types examined, with the exception of liver and colorectal cancer.

Keyword

Early detection of cancer; Trends; Health care surveys

MeSH Terms

Breast
Breast Neoplasms
Cervix Uteri
Colorectal Neoplasms
Cross-Sectional Studies
Early Detection of Cancer
Family Characteristics
Female
Health Care Surveys
Humans
Korea
Liver
Liver Neoplasms
Male
Mass Screening
Stomach Neoplasms
Uterine Cervical Neoplasms

Figure

• 

  Fig. 1 Cancer screening rates with recommendation by gender, 2004-2012.

• 

  Fig. 2 Cancer screening rates with recommendation by age, 2004-2012.

• 

  Fig. 3 Cancer screening rates with recommendation by household income level, 2004-2012. Monthly household income status classified by tertile.

Reference

1. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44:11–24. PMID: 22500156.

2. Lee YY, Oh DK, Choi KS, Jung KW, Lee HY, Jun JK. The current status of gastric cancer screening in Korea: report on the National Cancer Screening Programme, 2009. Asian Pac J Cancer Prev. 2011; 12:3495–3500. PMID: 22471504.

3. Noh DK, Choi KS, Jun JK, Lee HY, Park EC. Factors associated with attending the National Cancer Screening Program for liver cancer in Korea. Asian Pac J Cancer Prev. 2012; 13:731–736. PMID: 22524852.

4. Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, et al. Results of colorectal cancer screening of the National Cancer Screening Program in Korea, 2008. Cancer Res Treat. 2010; 42:191–198. PMID: 21253320.

5. Oh DK, Shim JI, Han M, Kim Y, Lee HY, Jun JK, et al. Breast cancer screening in Korean women: report of the National Cancer Screening Program in 2008. J Breast Cancer. 2010; 13:299–304.

6. Lee YH, Choi KS, Lee HY, Jun JK. Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009. J Gynecol Oncol. 2012; 23:16–21. PMID: 22355462.

7. Lee HY, Park EC, Jun JK, Hahm MI, Jung KW, Kim Y, et al. Trends in socioeconomic disparities in organized and opportunistic gastric cancer screening in Korea (2005-2009). Cancer Epidemiol Biomarkers Prev. 2010; 19:1919–1926. PMID: 20647409.

8. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:335–351. PMID: 10649300.

9. Han MA, Choi KS, Park JH, Moore MA, Park EC. Midcourse evaluation of the second-term 10-Year Plan for Cancer Control in Korea. Asian Pac J Cancer Prev. 2011; 12:327–333. PMID: 21517281.

10. NHS Cancer Screening Programmes. NHS Breast Screening Programme: annual review 2011 [Internet]. Sheffield: NHS Cancer Screening Programmes;2011. cited 2012 Dec 30. Available from: http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-annualre-view2011.pdf .

11. The NHS Information Centre. NHS Breast Screening Programme: annual review 2011 [Internet]. Sheffield: NHS Cancer Screening Programmes;2011. cited 2012 Dec 30. Available from: http://www.cancerscreening.nhs.uk/breastscreen/breast-statistics-bulletin-2009-10.pdf .

12. NHS Cancer Screening Programmes. NHS Cervical Screening Programme: annual review 2011 [Internet]. Sheffield: NHS Cancer Screening Programmes;2011. cited 2012 Dec 30. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/cervical-annual-review-2011.pdf .

13. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011; 61:8–30. PMID: 21205832.

14. National Cancer Institute. Cancer trends progress report: 2011/2012 update. Colorectal cancer screening [Internet]. Bethesda, MD: National Cancer Institute;2012. cited 2012 Dec 30. Available from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&coid=918&mid= .

15. National Cancer Institute. Cancer trends progress report: 2011/2012 update. Breast cancer screening [Internet]. Bethesda, MD: National Cancer Institute;2012. cited 2012 Dec 30. Available from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&coid=916&mid=#trends .

16. National Cancer Institute. Cancer trends progress report: 2011/2012 update. Cervical cancer screening [Internet]. Bethesda, MD: National Cancer Institute;2012. cited 2012 Dec 30. Available from: http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2009&chid=92&coid=917&mid=#trends .

17. Yoshida M, Kondo K, Tada T. The relation between the cancer screening rate and the cancer mortality rate in Japan. J Med Invest. 2010; 57:251–259. PMID: 20847525.

18. OECD. Health at a glance 2009: OECD indicators. Screening, survival and mortality for cervical cancer [Internet]. OECD iLibrary;2011. cited 2012 Dec 30. Available from: http://www.oecd-ilibrary.org/docserver/download/8109111ec054.pdf?expires=1356786645&id=id&accname=guest&checksum=1686480C1DB188423551F0E89AC80D67 .

19. OECD. Health at a galance 2009: OECD indicators. Screening, survival and mortality for breast cancer [Internet]. OECD iLibrary;2011. cited 2012 Dec 30. Available from: http://www.oecdilibrary.org/docserver/download/8109111ec055.pdf?expires=1356786924&id=id&accname=guest&checksum=2AD9534B55A7A6B54E7BCFF5F8C467F5 .

20. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev. 2003; 12(11 Pt 1):1182–1187. PMID: 14652278.

21. Hoffmeister M, Chang-Claude J, Brenner H. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk. Am J Epidemiol. 2007; 166:130–136. PMID: 17456475.

22. Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomarkers Prev. 2008; 17:777–784. PMID: 18381476.

23. Ock SM, Choi JY, Cha YS, Lee J, Chun MS, Huh CH, et al. The use of complementary and alternative medicine in a general population in South Korea: results from a national survey in 2006. J Korean Med Sci. 2009; 24:1–6. PMID: 19270805.

24. Park B, Lee YK, Cho LY, Go UY, Yang JJ, Ma SH, et al. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. J Korean Med Sci. 2011; 26:711–719. PMID: 21655054.

25. Seo HJ, Sung YK, Choi CB, Lee EB, Cheong C, Kim SY, et al. Prevalence and factors affecting glucosamine use in Korea: a survey-based study. Rheumatol Int. 2013; 33:1627–1631. PMID: 22200808.